Table of Contents Author Guidelines Submit a Manuscript
Bioinorganic Chemistry and Applications
Volume 2015 (2015), Article ID 751013, 6 pages
http://dx.doi.org/10.1155/2015/751013
Research Article

Arsenic Primes Human Bone Marrow CD34+ Cells for Erythroid Differentiation

1Key Laboratory of Cardiovascular Remodeling and Function Research, Qilu Hospital, Shandong University, Jinan, Shandong 250012, China
2Department of Oncology and Pathology (CCK), R8:03, Karolinska University Hospital, Solna, 17176 Stockholm, Sweden
3Department of Hematology, Qilu Hospital, Shandong University, Jinan, Shandong 250012, China

Received 11 November 2014; Revised 20 May 2015; Accepted 26 May 2015

Academic Editor: Francesco P. Fanizzi

Copyright © 2015 Yuanyuan Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S.-J. Chen, G.-B. Zhou, X.-W. Zhang, J.-H. Mao, H. De Thé, and Z. Chen, “From an old remedy to a magic bullet: molecular mechanisms underlying the therapeutic effects of arsenic in fighting leukemia,” Blood, vol. 117, no. 24, pp. 6425–6437, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. J.-X. Liu, G.-B. Zhou, S.-J. Chen, and Z. Chen, “Arsenic compounds: revived ancient remedies in the fight against human malignancies,” Current Opinion in Chemical Biology, vol. 16, no. 1-2, pp. 92–98, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Lengfelder, W.-K. Hofmann, and D. Nowak, “Impact of arsenic trioxide in the treatment of acute promyelocytic leukemia,” Leukemia, vol. 26, no. 3, pp. 433–442, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Singh, D. Kumar, and A. P. Sahu, “Arsenic in the environment: effects on human health and possible prevention,” Journal of Environmental Biology, vol. 28, no. 2, pp. 359–365, 2007. View at Google Scholar · View at Scopus
  5. E. Saulle, R. Riccioni, E. Pelosi et al., “In vitro dual effect of arsenic trioxide on hemopoiesis: inhibition of erythropoiesis and stimulation of megakaryocytic maturation,” Blood Cells, Molecules, and Diseases, vol. 36, no. 1, pp. 59–76, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Vernhet, C. Morzadec, J. van Grevenynghe et al., “Inorganic arsenic induces necrosis of human CD34-positive haematopoietic stem cells,” Environmental Toxicology, vol. 23, no. 2, pp. 263–268, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Valgimigli, G. M. Rigolin, A. Fucili et al., “CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure,” Circulation, vol. 110, no. 10, pp. 1209–1212, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Jing, U. Oelschlaegel, R. Ordemann et al., “CD49d blockade by natalizumab in patients with multiple sclerosis affects steady-state hematopoiesis and mobilizes progenitors with a distinct phenotype and function,” Bone Marrow Transplantation, vol. 45, no. 10, pp. 1489–1496, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. T. D. Schreiber, C. Steinl, M. Essl et al., “The integrin α9β1 on hematopoietic stem and progenitor cells: Involvement in cell adhesion, proliferation and differentiation,” Haematologica, vol. 94, no. 11, pp. 1493–1501, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. D. A. Breems, E. A. W. Blokland, K. E. Siebel, A. E. M. Mayen, L. J. A. Engels, and R. E. Ploemacher, “Stroma-contact prevents loss of hematopoietic stem cell quality during ex vivo expansion of CD34+ mobilized peripheral blood stem cells,” Blood, vol. 91, no. 1, pp. 111–117, 1998. View at Google Scholar · View at Scopus
  11. G. G. Koliakos, D. H. Alamdari, N. Tsagias, K. Kouzi-Koliakos, E. Michaloudi, and V. Karagiannis, “A novel high-yield volume-reduction method for the cryopreservation of UC blood units,” Cytotherapy, vol. 9, no. 7, pp. 654–659, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. H. E. Broxmeyer, E. F. Srour, G. Hangoc, S. Cooper, S. A. Anderson, and D. M. Bodine, “High-efficiency recovery of functional hematopoietic progenitor and stem cells from human cord blood cryopreserved for 15 years,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 2, pp. 645–650, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. F. F. Liu, X. Wu, Y. Zhang, Y. Wang, and F. Jiang, “TRAIL/DR5 signaling promotes macrophage foam cell formation by modulating scavenger receptor expression,” PLoS ONE, vol. 9, no. 1, Article ID e87059, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. D. A. Newton, K. M. K. Rao, R. A. Dluhy, and J. E. Baatz, “Hemoglobin is expressed by alveolar epithelial cells,” The Journal of Biological Chemistry, vol. 281, no. 9, pp. 5668–5676, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. X. S. Xu, X. Hong, and G. Wang, “Induction of endogenous gamma-globin gene expression with decoy oligonucleotide targeting Oct-1 transcription factor consensus sequence,” Journal of Hematology and Oncology, vol. 2, article 15, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. B. B. Lerman, N. Ali, and D. Green, “Megaloblastic, dyserythropoietic anemia following arsenic ingestion,” Annals of Clinical and Laboratory Science, vol. 10, no. 6, pp. 515–517, 1980. View at Google Scholar · View at Scopus
  17. D. D. Westhoff, R. J. Samaha, and A. Barnes Jr., “Arsenic intoxication as a cause of megaloblastic anemia,” Blood, vol. 45, no. 2, pp. 241–246, 1975. View at Google Scholar · View at Scopus
  18. S. J. S. Flora, “Arsenic-induced oxidative stress and its reversibility,” Free Radical Biology and Medicine, vol. 51, no. 2, pp. 257–281, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Chen, Y. Liu, R. Liu et al., “TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species,” Journal of Experimental Medicine, vol. 205, no. 10, pp. 2397–2408, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Rizo, S. Olthof, L. Han, E. Vellenga, G. de Haan, and J. J. Schuringa, “Repression of BMI1 in normal and leukemic human CD34+ cells impairs self-renewal and induces apoptosis,” Blood, vol. 114, no. 8, pp. 1498–1505, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Owusu-Ansah and U. Banerjee, “Reactive oxygen species prime Drosophila haematopoietic progenitors for differentiation,” Nature, vol. 461, no. 7263, pp. 537–541, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. F. K. Tounkara, N. Dumont, S. Fournier, L. Boyer, P. Nadeau, and N. Pineault, “Mild hyperthermia promotes and accelerates development and maturation of erythroid cells,” Stem Cells and Development, vol. 21, no. 17, pp. 3197–3208, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. X. M. Hu, B. Yuan, S. Tanaka et al., “Arsenic disulfide-triggered apoptosis and erythroid differentiation in myelodysplastic syndrome and acute myeloid leukemia cell lines,” Hematology, vol. 19, no. 6, pp. 352–360, 2014. View at Publisher · View at Google Scholar
  24. A. S. Tsiftsoglou, I. D. Bonovolias, and S. A. Tsiftsoglou, “Multilevel targeting of hematopoietic stem cell self-renewal, differentiation and apoptosis for leukemia therapy,” Pharmacology and Therapeutics, vol. 122, no. 3, pp. 264–280, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Nowak, D. Stewart, and H. P. Koeffler, “Differentiation therapy of leukemia: 3 decades of development,” Blood, vol. 113, no. 16, pp. 3655–3665, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. G. A. dos Santos, L. Kats, and P. P. Pandolfi, “Synergy against PML-RARa: targeting transcription, proteolysis, differentiation, and self-renewal in acute promyelocytic leukemia,” Journal of Experimental Medicine, vol. 210, no. 13, pp. 2793–2802, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Petrie, A. Zelent, and S. Waxman, “Differentiation therapy of acute myeloid leukemia: past, present and future,” Current Opinion in Hematology, vol. 16, no. 2, pp. 84–91, 2009. View at Publisher · View at Google Scholar · View at Scopus